Illegal drug treatments and drug metabolism: Biomarkers or not?

Veterinary Research Communications

Volumn 30, Issue SUPPL. 1, 2006, Pages 113-119

  Dacasto, Mauro ^a   Montesissa, C ^a   Nebbia, C ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Biomarkers; Cattle; Drug metabolizing enzymes; Illicit drug; Poultry

Indexed keywords

BIOLOGICAL MARKER; BOLDENONE; BOLDIONE; CLENBUTEROL; CYTOCHROME A1; CYTOCHROME C OXIDASE; CYTOCHROME C2; DEXAMETHASONE; DRUG METABOLIZING ENZYME; ESTRADIOL; PRASTERONE; TESTOSTERONE;

ANIMAL HUSBANDRY; ARTICLE; DNA MICROARRAY; DRUG EXPOSURE; DRUG METABOLISM; ENZYME INDUCTION; ENZYME INHIBITION; FOOD ANALYSIS; FOOD CONTAMINATION; FOOD QUALITY; FOOD SAFETY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNOBLOTTING; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TOXICOKINETICS;

BOS TAURUS;

EID: 33748438699     PISSN: 01657380     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11259-006-0023-y     Document Type: Article

References (31)

1. Cantiello, M., Carletti M., Merlanti, R., Gusson, F., Cannizzo, T., Capolongo, F., Nebbia, C. and Dacasto, M., 2003. Effects of the illegal oral and intramuscular administration of dexamethasone (DEX) upon liver CYP3A expression in veal calves. Drug Metabolism Reviews, 35 (1), 76
2. Cantiello, M., Carletti, M., Monziols, M., Nebbia, C. and Dacasto, M., 2002. Effects of the repeated oral administration of cimaterol and clenbuterol upon the liver drug metabolizing enzymes activities (DMEs) in the male chick. Proceedings of the 20th Meeting of the European Society of Veterinary Pathology, Grugliasco (Turin), September 18-21, 2002, 95
3. Capolongo, F., Dacasto, M., Carletti, M., Nebbia, C., Merlanti, R. and Montesissa, C., 2004. Effetti di alcuni trattamenti illeciti sul metabolismo ossidativo P450-dipendente nel fegato del vitello a carne bianca: Risultati preliminari. Atti S.I.S.Vet., LVIII, 130
4. Cascales Angosto, M. and Gómez-Lechón, M.J., 2004. Citocromo P-450, (Realigraf S.A., Madrid)
5. Ciolino, H.P. and Yeh, G.C., 1999. The steroid hormone dehydroepiandrosterone inhibits CYP1A1 expression in vitro by a post-transcriptional mechanism. Journal of Biological Chemistry, 274, 35186-35190
6. Dacasto, M., Eeckhoutte, C., Capolongo, F., Dupuy, J., Carletti, M., Calleja, C., Nebbia, C., Alvinerie, M. and Galtier, P., 2005. Effect of breed and gender on bovine liver cytochrome P450 3A (CYP3A) expression and inter-species comparison with other domestic ruminants. Veterinary Research, 36, 179-190
7. Galteau, M.M. and Samsa, F., 2003. Urinary 6β-hydroxycortisol: A validated test for evaluating drug induction or drug inhibition mediated through CYP3A in humans and animals. European Journal of Clinical Pharmacology, 59, 713-733
8. Groot, M.J., Schilt, R., Ossenkoppele, J.S., Berende, P.L. and Haasnoot, W., 1998. Combinations of growth promoters in veal calves: Consequences for screening and confirmation methods. Journal of Veterinary Medicine, Series A, 45, 425-440
9. Iber, H., Chen, Q., Sewer, M. and Morgan, E.T., 1997. Regulation of hepatic cytochrome P450 2C11 by glucocorticoids. Archives of Biochemistry and Biophysics, 345, 305-310
10. Klinger, W., Lupp, A., Karge, E., Baumbach, H., Eichhorn, F., Feix, A., Füldner, F., Gernhardt, S., Knels, L., Kost, B., Mertens, G., Werner, F., Oettel, M., Römer, W. Schwarz, S., Elger, W. and Schneider, B., 2002. Estradiol, testosterone, dehydroepiandrosterone and androstenedione: Novel derivatives and enantiomers. Interactions with rat liver cytochrome P450 and antioxidant/radical scavengers activities in vitro. Toxicology Letters, 128, 129-144
11. Lee, A.J., Cai, M.X., Thomas, P.E., Conney, A.H. and Zhu, B.T., 2003. Characterization of the oxidative metabolites of 17β -estradiol and estrone formed by 15 selectively expressed human cytochrome P450 isoforms. Endocrinology, 144, 3382-3398
12. Lison, D., 1999. Importance of biotransformation pathways for interpreting biological monitoring of exposure. Toxicology Letters, 108, 91-97
13. Luo, G., Guenthner T., Gan, L.S. and Humphreys, W.G., 2004. CYP3A4 induction by xenobiotics: Biochemistry, experimental methods and impact on drug discovery and development. Current Drug Metabolism, 5, 483-505
14. Machala, M., Souček, P., Nea, J., Ulrich, R., Lamka, J., Szotaáková, B. and Skálová, L., 2003. Inter-species comparisons of hepatic cytochrome P450 enzyme levels in male ruminants. Archives of Toxicology, 77, 555-560
15. Mugford, C.A. and Kedderis, G.L., 1998. Sex-dependent metabolism of xenobiotics. Drug Metabolism Reviews, 30, 441-498
16. Mutti, A., 1999. Biological monitoring in occupational and environmental toxicology. Toxicology Letters, 108, 77-89
17. Nebbia, C., Dacasto, M., Ceppa, L. and Roncada, P., 1996. Changes in the activities of hepatic xenobiotic metabolising enzymes after the administration of clenbuterol to female broilers. Research in Veterinary Science, 60, 33-36
18. Nebbia, C., 2001. Biotransformation enzymes as determinants of xenobiotic toxicity in domestic animals. The Veterinary Journal, 161, 238-252
19. Nebbia, C., Dacasto, M., Rossetto Giaccherino, A., Giuliano Albo, A. and Carletti, M., 2003a. Comparative expression of liver cytochrome P450-dependent monooxygenases in the horse and in other agricultural and laboratory species. The Veterinary Journal, 165, 53-64
20. Nebbia, C., Cantiello, M., Dacasto, M., Capolongo, F., Merlanti, R., Gusson, F. and Carletti, M., 2003b. Inhibition of in vitro xenobiotic- and testosterone metabolism in liver microsomes from veal calves experimentally treated with a combination of 17β -oestradiol, clenbuterol and dexamethasone. Journal of Veterinary Pharmacology and Therapeutics, 26 (1), 192
21. Ourlin, J.C., Baader, M., Fraser, D., Halpert, J.R. and Meyer, U.A., 2000. Cloning and functional expression of a first inducible avian cytochrome P450 of the CYP3A subfamily (CYP3A37). Archives of Biochemistry and Biophysics, 373, 375-384
22. Rendic, S. and Di Carlo, F.J., 1997. Human cytochrome P450 enzymes: A status report summarizing their reactions, substrates, inducers and inhibitors. Drug Metabolism Reviews, 29, 413-580
23. Ringel, M., Oesch, F., Gerl, M., Klebach, M., Quint, M., Bader, A., Bottger, T. and Hengstler, J.G., 2002. Permissive and suppressive effects of dexamethasone on enzyme induction in hepatocyte co-cultures. Xenobiotica, 32, 653-666
24. Sivapathasundaram, S., Magnisali, P., Coldham, N.G., Howells, L.C., Sauer, M.J. and Ioannides, C., 2001. A study of the expression of the xenobiotic-metabolising cytochrome P450 proteins and of testosterone metabolism in bovine liver. Biochemical Pharmacology, 62, 635-645
25. Szotáková B, Baliharová, V., Lamka, J., Noinová, E., Wsól, V., Velík, J., Machala, M., Neča, J., Souček, P., Šusová, S. and Skálová, L., 2004. Comparison of in vitro activities of biotransformation enzymes in pig, cattle, goat and sheep. Research in Veterinary Science, 76, 43-51
26. Timbrell, J.A., 1998. Biomarkers in toxicology. Toxicology, 129, 1-12
27. Toffolatti, L., Rosa Gastaldo, L., Patarnello, T., Romualdi, C., Merlanti, R., Montesissa, C., Poppi, L., Castagnaro, M. and Bargelloni, L., 2006. Expression analysis of androgen-responsive genes in the prostate of veal calves treated with anabolic hormones. Domestic Animal Endocrinology, 30, 38-55
28. Tom, M. and Auslander, M., 2005. Transcript and protein environmental biomarkers in fish - a review. Chemosphere, 59, 155-162
29. Vainio, H., 1998. Use of biomarkers - new frontiers in occupational toxicology and epidemiology. Toxicology Letters, 102 - 103, 581-589
30. Witkamp, R.F., van't Klooster, G.A., Nijmeijer, S.M., Kolker, H.J., Noordhoek, J. and van Miert, A.S., 1993. Hormonal regulation of oxidative drug metabolism in the dwarf gorat. The effect of sex and hormonal treatment on plasma disposition and metabolite formation of sulphadimidine. Journal of Veterinary Pharmacology and Therapeutics, 16, 55-62
31. Yan, Z. and Caldwell, G.W., 2001. Metabolism profiling, and cytochrome P450 inhibition & induction in drug discovery. Current Topics in Medicinal Chemistry, 1, 403-425